Literature DB >> 21321532

Blockade of IL-6 signaling exacerbates liver injury and suppresses antiapoptotic gene expression in methionine choline-deficient diet-fed db/db mice.

Kanji Yamaguchi1, Yoshito Itoh, Chihiro Yokomizo, Takeshi Nishimura, Toshihisa Niimi, Atsushi Umemura, Hideki Fujii, Takeshi Okanoue, Toshikazu Yoshikawa.   

Abstract

Our previous study revealed that blockade of interleukin-6 (IL-6)-STAT3 signaling ameliorated liver injury, although hepatic STAT3(-/-) or GP130(-/-) mice have been reported to develop severe liver injury, in a murine methionine choline deficient (MCD) diet-induced model of non-alcoholic steatohepatitis (NASH). In this study, to determine whether profound blockade of IL-6-STAT3 signaling may still ameliorate liver injury, we studied db/db mice, which have impaired leptin-mediated STAT3 activation, using the MCD diet-induced NASH model. Male lean and db/db mice (6 weeks old) were fed either control chow or an MCD diet for 8 or 12 weeks. Half of the mice were treated with 15 mg/kg rat anti-mouse IL-6 receptor neutralizing antibody (MR16-1) intraperitoneally twice weekly, the remainder were injected with 15 mg/kg rat IgG as a control. Hepatic steatosis, injury, fibrosis, markers of lipid peroxidation/oxidant stress and antiapoptotic gene expression were evaluated. Plasma IL-6 levels were elevated in all groups of db/db mice. Although hepatic IL-6/ GP130 signaling was activated in chow-fed db/db mice, this was suppressed in MCD diet-fed db/db mice, accompanied by downregulation of hepatic IL-6 receptor and GP130 mRNA expression. MR16-1 treatment of MCD diet-fed db/db mice further repressed STAT3 activities and expression of STAT3-related antiapoptotic genes, such as Bcl-2 and Ref-1, but increased plasma-free fatty acid and hepatic markers of lipid peroxidation/oxidant stress, leading to increased liver injury, hepatocyte apoptosis and liver fibrosis. Although 'moderate' blockade of enhanced IL-6-STAT3 signaling may be beneficial in NASH, as we reported previously, these findings demonstrate that a profound defect in STAT3 activation is detrimental in terms of liver injury, hepatocyte apoptosis and liver fibrosis, indicating the hepato-protective role of IL-6 signaling in this severe NASH model.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21321532     DOI: 10.1038/labinvest.2011.2

Source DB:  PubMed          Journal:  Lab Invest        ISSN: 0023-6837            Impact factor:   5.662


  16 in total

Review 1.  Concordance of preclinical and clinical pharmacology and toxicology of therapeutic monoclonal antibodies and fusion proteins: cell surface targets.

Authors:  Peter J Bugelski; Pauline L Martin
Journal:  Br J Pharmacol       Date:  2012-06       Impact factor: 8.739

Review 2.  Adipokines and proinflammatory cytokines, the key mediators in the pathogenesis of nonalcoholic fatty liver disease.

Authors:  Sanja Stojsavljević; Marija Gomerčić Palčić; Lucija Virović Jukić; Lea Smirčić Duvnjak; Marko Duvnjak
Journal:  World J Gastroenterol       Date:  2014-12-28       Impact factor: 5.742

Review 3.  Role of cytokines and chemokines in non-alcoholic fatty liver disease.

Authors:  Vincent Braunersreuther; Giorgio Luciano Viviani; François Mach; Fabrizio Montecucco
Journal:  World J Gastroenterol       Date:  2012-02-28       Impact factor: 5.742

4.  The effect of pH dependence of antibody-antigen interactions on subcellular trafficking dynamics.

Authors:  Siva Charan Devanaboyina; Sandra M Lynch; Raimund J Ober; Sripad Ram; Dongyoung Kim; Alberto Puig-Canto; Shannon Breen; Srinath Kasturirangan; Susan Fowler; Li Peng; Haihong Zhong; Lutz Jermutus; Herren Wu; Carl Webster; E Sally Ward; Changshou Gao
Journal:  MAbs       Date:  2013 Nov-Dec       Impact factor: 5.857

5.  IκB kinase-beta inhibitor attenuates hepatic fibrosis in mice.

Authors:  Jue Wei; Min Shi; Wei-Qi Wu; Hui Xu; Ting Wang; Na Wang; Jia-Li Ma; Yu-Gang Wang
Journal:  World J Gastroenterol       Date:  2011-12-21       Impact factor: 5.742

6.  Interleukin-6 enhances insulin secretion by increasing glucagon-like peptide-1 secretion from L cells and alpha cells.

Authors:  Helga Ellingsgaard; Irina Hauselmann; Beat Schuler; Abdella M Habib; Laurie L Baggio; Daniel T Meier; Elisabeth Eppler; Karim Bouzakri; Stephan Wueest; Yannick D Muller; Ann Maria Kruse Hansen; Manfred Reinecke; Daniel Konrad; Max Gassmann; Frank Reimann; Philippe A Halban; Jesper Gromada; Daniel J Drucker; Fiona M Gribble; Jan A Ehses; Marc Y Donath
Journal:  Nat Med       Date:  2011-10-30       Impact factor: 53.440

7.  Knockout of sulfatase 2 is associated with decreased steatohepatitis and fibrosis in a mouse model of nonalcoholic fatty liver disease.

Authors:  Tae Hyo Kim; Bubu A Banini; Faizal Z Asumda; Nellie A Campbell; Chunling Hu; Catherine D Moser; Abdirashid M Shire; Shaoshan Han; Chenchao Ma; Anuradha Krishnan; Taofic Mounajjed; Thomas A White; Gregory J Gores; Nathan K LeBrasseur; Michael R Charlton; Lewis Rowland Roberts
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2020-07-20       Impact factor: 4.052

8.  Epidermal growth factor receptor restoration rescues the fatty liver regeneration in mice.

Authors:  Teresa A Zimmers; Xiaoling Jin; Zongxiu Zhang; Yanlin Jiang; Leonidas G Koniaris
Journal:  Am J Physiol Endocrinol Metab       Date:  2017-06-27       Impact factor: 4.310

9.  Sex hormone affects the severity of non-alcoholic steatohepatitis through the MyD88-dependent IL-6 signaling pathway.

Authors:  Guangda Xin; Shaoyou Qin; Song Wang; Xu Wang; Yonggui Zhang; Jiangbin Wang
Journal:  Exp Biol Med (Maywood)       Date:  2015-03-18

10.  N-Acetylcysteine Prevents Post-embolization Syndrome in Patients with Hepatocellular Carcinoma Following Transarterial Chemoembolization.

Authors:  Sith Siramolpiwat; Thanachai Punjachaipornpon; Bubpha Pornthisarn; Ratha-Korn Vilaichone; Soonthorn Chonprasertsuk; Anupong Tangaroonsanti; Patommatat Bhanthumkomol; Achara Phumyen; Atipat Yasiri; Mayurachat Kaewmanee
Journal:  Dig Dis Sci       Date:  2019-05-09       Impact factor: 3.487

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.